Skip to the main content.

Cell and Gene Therapy Series. Part 3 - Clusters, Megadeals, "Cellicon Valley" and the "Golden Triangle

In this third instalment to our cell and gene blog series, author Dave Seaward explains where most ATMP technology is being delivered as well as providing insight into why.

Click here to gain an understanding of why investors believe significant returns will be made from these technologies.

Custom aseptic extrusion: Why it's a game-changer

Custom aseptic extrusion: Why it's a game-changer

Pharmaceutical extrusion is a critical process in the manufacturing of advanced drug delivery systems, from long-acting injectables to solid...

Read More
Responding to cell & gene fill-finish and automation scale-up challenges

Responding to cell & gene fill-finish and automation scale-up challenges

Before delving into some technical details of cell and gene therapy manufacturing, it’s worth pausing to reflect on the human stories that drive this...

Read More
Jaw Crimping VS Rotary Crimping: Enhancing aseptic assurance.

Jaw Crimping VS Rotary Crimping: Enhancing aseptic assurance.

In the aseptic fill-finish world, crimping is more than just a mechanical operation - it's a critical control point for safeguarding sterility and...

Read More